Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology
Overview
Cell Biology
Molecular Biology
Authors
Affiliations
Dietary interventions are potentially effective therapies for inflammatory bowel diseases (IBDs). We tested the effect of 4-day fasting-mimicking diet (FMD) cycles on a chronic dextran sodium sulfate (DSS)-induced murine model resulting in symptoms and pathology associated with IBD. These FMD cycles reduced intestinal inflammation, increased stem cell number, stimulated protective gut microbiota, and reversed intestinal pathology caused by DSS, whereas water-only fasting increased regenerative and reduced inflammatory markers without reversing pathology. Transplants of Lactobacillus or fecal microbiota from DSS- and FMD-treated mice reversed DSS-induced colon shortening, reduced inflammation, and increased colonic stem cells. In a clinical trial, three FMD cycles reduced markers associated with systemic inflammation. The effect of FMD cycles on microbiota composition, immune cell profile, intestinal stem cell levels and the reversal of pathology associated with IBD in mice, and the anti-inflammatory effects demonstrated in a clinical trial show promise for FMD cycles to ameliorate IBD-associated inflammation in humans.
The cyclic metabolic switching theory of intermittent fasting.
Mattson M Nat Metab. 2025; .
PMID: 40087409 DOI: 10.1038/s42255-025-01254-5.
Momoh M, Adeniran F, Ramos C, DelGiorno K, Seno H, Roland J Physiol Rep. 2025; 13(5):e70264.
PMID: 40051209 PMC: 11885799. DOI: 10.14814/phy2.70264.
Kwon J, Kawase H, Mattonet K, Guenther S, Hahnefeld L, Shamsara J Nat Commun. 2025; 16(1):1448.
PMID: 39920161 PMC: 11805951. DOI: 10.1038/s41467-025-56713-0.
Song S, Zhang X, Zheng H, Liao Y, Tang P, Liu Y Food Sci Nutr. 2025; 13(2):e70014.
PMID: 39898122 PMC: 11787962. DOI: 10.1002/fsn3.70014.
Management of Overweight and Obesity in Patients With Inflammatory Bowel Disease.
Shneyderman M, Freid H, Kohler D, Peraza J, Haskey N, Abbott E Gastroenterol Hepatol (N Y). 2025; 20(12):712-722.
PMID: 39886003 PMC: 11776002.